Cystitis News and Research RSS Feed - Cystitis News and Research

Cystitis is inflammation of the urinary bladder. The condition more often affects women, but can affect either sex and all age groups.
Researchers show how spinal cord injury causes profound changes in gut microbiota

Researchers show how spinal cord injury causes profound changes in gut microbiota

The community of bacteria that live in our intestines, also called the "gut microbiome," is important to normal intestinal function. [More]
Researchers examine link between leisure-time physical activity and bacterial infections

Researchers examine link between leisure-time physical activity and bacterial infections

The risk of viral infections is known to be affected by physical activity, but little information is available regarding the more serious infections caused by bacteria. [More]
New discovery could lead to effective treatment methods for cystitis

New discovery could lead to effective treatment methods for cystitis

Every year, millions of people are treated for cystitis, but despite its prevalence, the disease is still a scientific mystery. [More]
First clinical trial to study use of Chinese Herbal Medicines in treating RUTIs

First clinical trial to study use of Chinese Herbal Medicines in treating RUTIs

Researchers at the University of Southampton are to study the use of Chinese Herbal Medicines in treating recurrent urinary tract infections (RUTIs), in the first clinical trial of its kind in the UK. [More]
Research shows how recreational ketamine abuse harms the bladder

Research shows how recreational ketamine abuse harms the bladder

Research conducted by scientists at the University of York has revealed how recreational ketamine abuse damages the bladder [More]
Researchers discover how E. coli bacteria adhere to urinary tract

Researchers discover how E. coli bacteria adhere to urinary tract

Almost every second woman suffers from a bladder infection at some point in her life. Also men are affected by cystitis, though less frequently. In eighty percent of the cases, it is caused by the intestinal bacterium E. coli. [More]
Romosozumab for postmenopausal women with osteoporosis meets co-primary endpoints in Phase 3 study

Romosozumab for postmenopausal women with osteoporosis meets co-primary endpoints in Phase 3 study

Amgen and UCB today announced top-line results from the Phase 3 placebo-controlled FRActure study in postmenopausal woMen with ostEoporosis (FRAME). [More]
New ICN Food List app can help people struggling with urinary tract food sensitivity

New ICN Food List app can help people struggling with urinary tract food sensitivity

If you're scared to drink a cup of coffee out of fear that you'll spend the day in the restroom, you're not alone. Mild urinary frequency and urgency are common but for patients with urinary disorders, these same foods can provoke days of pain and discomfort. A new android application, the ICN Food List, seeks to change that by giving patients a reference guide that they can easily use while shopping and eating out at restaurants. [More]
New NICE-accredited guidelines on prevention and control of MDRGNB available online

New NICE-accredited guidelines on prevention and control of MDRGNB available online

Gram-negative bacteria (MDRGNB) include common types such as E. coli that all of us carry in our bowels. When these bacteria get into other parts of the body they can cause infections, including common infections such as cystitis or urinary tract infections. The bacteria can also be readily spread from person to person. Multi-drug-resistant strains are resistant to most, or all, of the common antibiotics that we use to treat infections. [More]
Imprimis, Advanced Dosage sign license agreement for proprietary compounded ophthalmic formulations

Imprimis, Advanced Dosage sign license agreement for proprietary compounded ophthalmic formulations

Imprimis Pharmaceuticals, Inc., a pharmaceutical company focused on the development and commercialization of proprietary compounded drug formulations, today announced that it has entered into a license agreement with Advanced Dosage Forms, Inc. to expand Imprimis' proprietary ophthalmic injectable and combination topical compounded formulations into Canada. Under the agreement, the licensee has the rights to formulate, market and sell these formulations across Canada. [More]
SUNY Downstate Medical Center researchers identify ALPIM syndrome as new spectrum disorder

SUNY Downstate Medical Center researchers identify ALPIM syndrome as new spectrum disorder

The relationship between mental and physical health is well established. But when mental and physical illnesses co-occur, patients' accounts of physical illness are sometimes arbitrarily discredited or dismissed by physicians. [More]
Study shows 28% decline in prostate cancer diagnoses following USPSTF recommendation against PSA testing

Study shows 28% decline in prostate cancer diagnoses following USPSTF recommendation against PSA testing

A new study led by Vanderbilt University Medical Center investigators found new diagnoses of prostate cancer in the U.S. declined 28 percent in the year following the draft recommendation from the United States Preventive Services Task Force against routine PSA screening for men. [More]
Botulinum toxin A effective for treating bladder disorders

Botulinum toxin A effective for treating bladder disorders

While Botulinum toxin A (BTX-A), known to the public as Botox, is commonly associated with smoothing wrinkles for a more youthful appearance, three studies presented at the 110th Annual Scientific Meeting of the American Urological Association are proving BTX-A to be more than just a cosmetic solution. [More]
Imprimis has exclusive US commercial rights for patented Hep-Lido-A formulation

Imprimis has exclusive US commercial rights for patented Hep-Lido-A formulation

Imprimis Pharmaceuticals, Inc., a pharmaceutical company focused on the development and commercialization of proprietary compounded drug formulations, today announced it now has the exclusive US commercial rights to the patented compounded alkalinized lidocaine and heparin formulation ("Hep-Lido-A" or "HLA") for the treatment of interstitial cystitis ("IC"), commonly referred to as painful bladder syndrome ("PBS"). [More]
Research findings lay groundwork for improving treatment assessment for men with prostate cancer

Research findings lay groundwork for improving treatment assessment for men with prostate cancer

UCLA researchers have found that radiation therapy is the most common treatment for men with prostate cancer regardless of the aggressiveness of the tumor, risk to the patient and overall patient prognosis. These findings lay the groundwork for improved treatment assessment by physicians and to better inform men fighting the disease. [More]
News study finds association between chronic fatigue syndrome and early menopause

News study finds association between chronic fatigue syndrome and early menopause

A newfound link between chronic fatigue syndrome (CFS) and early menopause was reported online today in Menopause, the journal of The North American Menopause Society. [More]
Urinary nerve growth factor shows diagnostic value

Urinary nerve growth factor shows diagnostic value

Urinary nerve growth factor could be a useful biomarker for the diagnosis of overactive bladder and a predictive biomarker to help guide treatment, Chinese researchers believe. [More]
Loyola announces opening of new acupuncture clinic for patients with pelvic health disorders

Loyola announces opening of new acupuncture clinic for patients with pelvic health disorders

Loyola University Health System will open an acupuncture clinic for men and women with pelvic health disorders this fall. The clinic will use acupuncture to treat patients with common conditions such as pelvic pain, nausea from pelvic surgery, interstitial cystitis, painful bladder syndrome, postoperative pain, prostatitis and overactive bladder. [More]
Scientists aim to understand and treat painful bladder condition

Scientists aim to understand and treat painful bladder condition

Taking advantage of technology that can analyze tissue samples and measure the activity of thousands of genes at once, scientists at Wake Forest Baptist Medical Center are on a mission to better understand and treat interstitial cystitis (IC), a painful and difficult-to-diagnose bladder condition. [More]
OAB and interstitial cystitis/bladder pain syndrome show considerable overlap

OAB and interstitial cystitis/bladder pain syndrome show considerable overlap

There is considerable overlap between symptoms in patients with interstitial cystitis/bladder pain syndrome and those with overactive bladder, US researchers have shown. [More]
Advertisement